Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Retained Earnings (2016 - 2026)

Nutex Health (NUTX) has disclosed Retained Earnings for 17 consecutive years, with -$239.4 million as the latest value for Q1 2026.

  • For Q1 2026, Retained Earnings rose 28.7% year-over-year to -$239.4 million; the TTM value through Mar 2026 reached -$239.4 million, up 28.7%, while the annual FY2025 figure was -$286.2 million, 19.83% up from the prior year.
  • Retained Earnings hit -$239.4 million in Q1 2026 for Nutex Health, up from -$286.2 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $521.3 million in Q2 2022 and bottomed at -$418.6 million in Q3 2024.
  • Average Retained Earnings over 5 years is -$286.7 million, with a median of -$357.0 million recorded in 2024.
  • On a YoY basis, Retained Earnings climbed as much as 2152.08% in 2022 and fell as far as 1176.78% in 2022.
  • Nutex Health's Retained Earnings stood at -$363.3 million in 2022, then decreased by 12.6% to -$409.1 million in 2023, then grew by 12.74% to -$357.0 million in 2024, then increased by 19.83% to -$286.2 million in 2025, then rose by 16.36% to -$239.4 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$239.4 million, -$286.2 million, and -$298.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.